Shabir Madhi to Antiviral Agents
This is a "connection" page, showing publications Shabir Madhi has written about Antiviral Agents.
Connection Strength
1,665
-
A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants. J Infect Dis. 2025 Mar 17; 231(3):e478-e487.
Score: 0,231
-
Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY). Vaccine. 2024 Oct 24; 42(24):126276.
Score: 0,223
-
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants. N Engl J Med. 2023 04 20; 388(16):1533-1534.
Score: 0,202
-
Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. N Engl J Med. 2022 03 03; 386(9):837-846.
Score: 0,187
-
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity. N Engl J Med. 2022 03 03; 386(9):892-894.
Score: 0,187
-
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. N Engl J Med. 2020 07 30; 383(5):415-425.
Score: 0,168
-
Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015 Nov; 3(11):888-900.
Score: 0,120
-
The bronchiolitis season is upon us--recommendations for the management and prevention of acute viral bronchiolitis. S Afr Med J. 2015 Sep 21; 105(7):525-6.
Score: 0,120
-
Influenza guideline for South Africa--update 2008. S Afr Med J. 2008 Mar; 98(3 Pt 2):224-30.
Score: 0,071
-
The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children S Afr Med J. 2024 10 08; 114(10):e2582.
Score: 0,056
-
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials. Lancet Child Adolesc Health. 2023 03; 7(3):180-189.
Score: 0,050
-
Acute viral bronchiolitis in South Africa: Strategies for management and prevention. S Afr Med J. 2016 Apr; 106(4):27-9.
Score: 0,031
-
South African guideline for the diagnosis, management and prevention of acute viral bronchiolitis in children. S Afr Med J. 2010 May 04; 100(5):320, 322-5.
Score: 0,021